Peijia Medical Limited
HKEX:9996.HK
2.95 (HKD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q2 | 2018 Q1 | 2017 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 216.255 | 224.871 | 132.034 | 118.799 | 84.845 | 51.689 | 24.416 | 14.239 | 13.46 | 5.239 | 4.675 | 4.675 | 0 | 0 | 0 |
| Cost of Revenue
| 63.842 | 51.914 | 39.035 | 35.597 | 26.591 | 14.289 | 8.147 | 5.285 | 4.855 | 1.831 | 1.672 | 1.672 | 0 | 0 | 0 |
| Gross Profit
| 152.413 | 172.957 | 92.999 | 83.202 | 58.254 | 37.4 | 16.269 | 8.954 | 8.605 | 3.408 | 3.003 | 3.003 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.705 | 0.769 | 0.704 | 0.7 | 0.687 | 0.724 | 0.666 | 0.629 | 0.639 | 0.651 | 0.642 | 0.642 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 132.214 | 172.589 | 300.223 | 83.428 | 323.133 | 131.291 | 68.278 | 41.164 | 42.303 | 16.221 | 13.784 | 13.784 | 6.963 | 6.963 | 6.963 |
| General & Administrative Expenses
| 79.254 | 62.383 | 63.823 | 59.609 | 61.343 | 53.082 | 52.647 | 65.325 | 144.429 | 28.938 | 10.933 | 10.933 | 2.153 | 2.153 | 2.153 |
| Selling & Marketing Expenses
| 152.888 | 172.093 | 148.96 | 92.67 | 71.573 | 21.679 | 15.964 | 5.162 | 6.181 | 1.301 | 1.871 | 1.871 | 0 | 0 | 0 |
| SG&A
| 232.142 | 234.476 | 212.783 | 152.279 | 132.916 | 74.761 | 68.611 | 70.487 | 150.61 | 30.239 | 12.803 | 12.803 | 2.153 | 2.153 | 2.153 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -26.561 | -26.561 | -26.561 | -29.732 | -29.732 | -29.732 |
| Operating Expenses
| 349.866 | 406.264 | 426.794 | 191.955 | 468.943 | 225.512 | 323.564 | 1,807.526 | 408.533 | 136.79 | 0.025 | 0.025 | -20.616 | -20.616 | -20.616 |
| Operating Income
| -183.774 | -143.256 | -185.186 | -137.931 | -149.237 | -86.632 | -111.344 | -97.38 | -178.776 | -41.875 | -132.789 | -132.789 | -20.616 | -20.616 | -20.616 |
| Operating Income Ratio
| -0.85 | -0.637 | -1.403 | -1.161 | -1.759 | -1.676 | -4.56 | -6.839 | -13.282 | -7.993 | -28.405 | -28.405 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 3.746 | -68.217 | -121.255 | 46.137 | -249.805 | -88.542 | -168.386 | -1,691.546 | -219.611 | -91.715 | -0.206 | -0.206 | -0.104 | -0.104 | -0.104 |
| Income Before Tax
| -180.028 | -211.473 | -306.441 | -91.794 | -399.042 | -175.174 | -279.73 | -1,788.926 | -398.387 | -133.59 | -132.994 | -132.994 | -20.719 | -20.719 | -20.719 |
| Income Before Tax Ratio
| -0.832 | -0.94 | -2.321 | -0.773 | -4.703 | -3.389 | -11.457 | -125.636 | -29.598 | -25.499 | -28.449 | -28.449 | 0 | 0 | 0 |
| Income Tax Expense
| 0.45 | 0.602 | 9.382 | 0.192 | 0 | 0 | 0 | 0 | 0 | 0.206 | 0.206 | 0.206 | 0.041 | 0.041 | 0.041 |
| Net Income
| -180.464 | -212.061 | -315.823 | -91.986 | -399.042 | -175.174 | -279.73 | -1,788.926 | -398.387 | -133.59 | -133.2 | -133.2 | -20.76 | -20.76 | -20.76 |
| Net Income Ratio
| -0.834 | -0.943 | -2.392 | -0.774 | -4.703 | -3.389 | -11.457 | -125.636 | -29.598 | -25.499 | -28.494 | -28.494 | 0 | 0 | 0 |
| EPS
| -0.26 | -0.31 | -0.47 | -0.14 | -0.6 | -0.27 | -0.38 | -8.68 | -1.7 | -0.6 | -0.22 | -0.22 | -0.034 | -0.034 | -0.034 |
| EPS Diluted
| -0.26 | -0.31 | -0.47 | -0.14 | -0.6 | -0.27 | -0.38 | -8.68 | -1.7 | -0.6 | -0.22 | -0.22 | -0.034 | -0.034 | -0.034 |
| EBITDA
| -164.253 | -126.004 | -170.779 | -121.794 | -137.42 | -75.193 | -101.621 | -89.249 | -171.492 | -37.381 | -129.454 | -129.454 | -19.423 | -19.423 | -19.423 |
| EBITDA Ratio
| -0.76 | -0.56 | -1.293 | -1.025 | -1.62 | -1.455 | -4.162 | -6.268 | -12.741 | -7.135 | -27.692 | -27.692 | 0 | 0 | 0 |